Estimates suggest that the United States comprises up to 80% of total global medical innovation. This is because the U.S. has a unique lack of price regulation on drugs, allowing pharmaceutical companies to thrive. However, leaders across the political spectrum including Clinton, Sanders, and Trump have been proposing the implementation of price controls on the pharmaceutical industry to slow rising drug prices.
With the recent ruling on the constitutionality of the Affordable Care Act, the U.S. healthcare system could change dramatically. The landmark bill that characterized the Obama Administration has suffered a serious blow, unless an appeal of the ruling is successful.